← Back to Search

Acceptance and Commitment Therapy for Cancer Pain Survivorship

N/A
Recruiting
Led By Susan Hong, MD, MPH
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Completed active therapy must have been curative in intent (for example stage IV cancer patients such as head and neck cancer patients treated with curative intent are eligible).
Self-reported cancer pain for >= 3 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is testing a new way to help cancer survivors with chronic pain, which may help them reduce their dependence on opioids.

Who is the study for?
This trial is for cancer survivors who are disease-free, have finished their primary therapy but still use opioids for pain. They must be part of the VCUHealth system and have had cancer-related pain for at least 3 months post-treatment. Those with a history of substance abuse or current psychotherapy for certain mental health issues cannot join.Check my eligibility
What is being tested?
The study tests Acceptance and Commitment Therapy (ACT-CP) to help long-term cancer survivors manage chronic pain without relying on opioids. It's a pilot trial to see if this behavioral intervention can reduce opioid dependence in patients who've completed curative treatment.See study design
What are the potential side effects?
Since ACT-CP is a form of therapy rather than medication, it may not have typical drug side effects. However, participants might experience emotional discomfort as they explore new ways to cope with chronic pain during the sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My previous cancer treatment was intended to cure me.
Select...
I have been experiencing cancer pain for 3 months or more.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Participant Satisfaction
Recruitment yield number of participants enrolled
Recruitment yield of participants consented
+2 more
Secondary outcome measures
Opioid Refill Frequency
Opioid Use Frequency
Pain Intensity
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Acceptance and Commitment Therapy for Chronic Pain (ACT-CP)

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor
697 Previous Clinical Trials
22,884,978 Total Patients Enrolled
Susan Hong, MD, MPHPrincipal InvestigatorVirginia Commonwealth University

Media Library

Acceptance and Commitment Therapy for chronic pain (ACT-CP) Clinical Trial Eligibility Overview. Trial Name: NCT05067556 — N/A
Cancer Pain Research Study Groups: Intervention
Cancer Pain Clinical Trial 2023: Acceptance and Commitment Therapy for chronic pain (ACT-CP) Highlights & Side Effects. Trial Name: NCT05067556 — N/A
Acceptance and Commitment Therapy for chronic pain (ACT-CP) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05067556 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Decreasing Long-term Opioid Use in Cancer Survivors
2021. "Decreasing Long-term Opioid Use in Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05067556.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top